Friday, September 20, 2019

Emmaus rescinds EU marketing application, following negative review - Endpoints News

Emmaus rescinds EU marketing application, following negative review  Endpoints News

“Because we have demonstrated the efficacy of Xyndari, as supported by the data from the trials conducted, we are disappointed in the CHMP's position,” chief ...



No comments:

Post a Comment